发明名称 |
MODIFIED FACTOR VIII. |
摘要 |
<p>The invention relates to the modification of human Factor VIII (FVIII) to result in FVIII proteins that are substantially non-immunogenic or less immunogenic than any non-modified counterpart when used in vivo. The invention relates furthermore to T-cell epitope peptides derived from said non-modified protein by means of which it is possible to create modified FVIII variants with reduced immunogenicity.</p> |
申请公布号 |
MXPA04010061(A) |
申请公布日期 |
2004.12.13 |
申请号 |
MX2004PA10061 |
申请日期 |
2003.04.17 |
申请人 |
MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG |
发明人 |
MATTHEW BAKER |
分类号 |
C12N15/09;A61K38/00;A61K38/10;A61K38/36;A61K38/37;A61K39/00;A61P7/00;A61P7/04;A61P37/06;C07K7/08;C07K14/755;C12N15/12;C12P21/02;(IPC1-7):A61K38/10 |
主分类号 |
C12N15/09 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|